Progress in the non-invasive biomarker space reveals new opportunities for their use in health diagnostics. These include risk assessment, early detection and monitoring of disease, patient stratification, and prediction of disease progression.

In this whitepaper we discuss:

• Harnessing non-invasive biomarker testing for medical and consumer health applications
• The non-invasive biomarker landscape for health screening and diagnostics
• Benefits of non-invasive biomarkers
• Challenges in implementation
• Suggest how challenges might be resolved with reliable, user-friendly, cost-effective solutions to help achieve commercialisation
• Maximising market opportunities in the non-invasive biomarker space

To read the whitepaper, please complete the form below.